Come up with a name for your new list and we'll add to it:
Azitra raised a round of funding on September 13, 2018. Investors include
U.S. Department of Defense.
Azitra is developing a recombinant strain of skin-safe bacterium that secrete therapeutic proteins. These proteins are missing from the skin's microbiome when a person suffers from problems like eczem…